articleCellJul 15, 2024Closed access

Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis

Shanghai Changzheng Hospital · East China Normal University · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

261
total citations
FWCI
65.55
Percentile
100%
References
58
Citations per year

Authors

41

Topics & keywords

Keywords
  • Immunology
  • Immune system
  • Chimeric antigen receptor
  • CD19
  • Biology
  • Myositis
  • Adverse effect
  • Cell therapy
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding